Company: HROW
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001641172-25-022980
Chunk: 2

Company: HARROW, INC.
Filing Date: 2025-08-11
Form: 10-Q
Item: Item 1
Chunk 2
---
,000  
    $111,402,000  
    $83,379,000 
  
    Other revenues 
     85,000  
     68,000  
     171,000  
     147,000 
  
    Total revenues 
     63,742,000  
     48,939,000  
     111,573,000  
     83,526,000 
  
    Cost of sales 
     (16,230,000) 
     (12,539,000) 
     (31,754,000) 
     (23,092,000)
  
    Gross profit 
     47,512,000  
     36,400,000  
     79,819,000  
     60,434,000 
  
    Operating expenses: 

    Selling, general and administrative 
     33,235,000  
     31,817,000  
     73,748,000  
     60,630,000 
  
    Research and development 
     2,868,000  
     3,053,000  
     5,894,000  
     5,202,000 
  
    Total operating expenses 
     36,103,000  
     34,870,000  
     79,642,000  
     65,832,000 
  
    Income (loss) from operations 
     11,409,000  
     1,530,000  
     177,000  
     (5,398,000)
  
    Other (expense) income: 

    Interest expense, net 
     (6,408,000) 
     (5,471,000) 
     (12,956,000) 
     (10,886,000)
  
    Investment loss from Eton Pharmaceuticals 
     -  
     (1,923,000) 
     -  
     (3,171,000)
  
    Other (expense) income, net 
     (6,000) 
     46,000  
     (6,000) 
     72,000 
  
    Total other expense, net 
     (6,414,000) 
     (7,348,000)